{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T01:32:36Z","timestamp":1772069556286,"version":"3.50.1"},"reference-count":28,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.1620\/tjem.234.83","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T23:13:36Z","timestamp":1409699616000},"page":"83-88","source":"Crossref","is-referenced-by-count":9,"title":["Expression of Anterior Gradient 2 Is Decreased with the Progression of Human Biliary Tract Cancer"],"prefix":"10.1620","volume":"234","author":[{"given":"Su Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Sejong General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongchul","family":"Kang","sequence":"additional","affiliation":[{"name":"Ilsong Institute of Life Science, Hallym University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hyeok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aberger, F., Weidinger, G., Grunz, H. &amp; Richter, K. (1998) Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2. <i>Mech. Dev.<\/i>, 72, 115-130.","DOI":"10.1016\/S0925-4773(98)00021-5"},{"key":"2","unstructured":"Barraclough, D.L., Platt-Higgins, A., de Silva Rudland, S., Barraclough, R., Winstanley, J., West, C.R. &amp; Rudland, P.S. (2009) The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. <i>Am. J. Pathol.<\/i>, 175, 1848-1857."},{"key":"3","doi-asserted-by":"crossref","unstructured":"Brychtova, V., Hermanova, M., Karasek, P., Lenz, J., Selingerova, I., Vojtesek, B., Kala, Z. &amp; Hrstka, R. (2014) Anterior gradient 2 and mucin 4 expression mirrors tumor cell differentiation in pancreatic adenocarcinomas, but aberrant anterior gradient 2 expression predicts worse patient outcome in poorly differentiated tumors. <i>Pancreas<\/i>, 43, 75-81.","DOI":"10.1097\/MPA.0b013e3182a63bc3"},{"key":"4","unstructured":"Brychtova, V., Vojtesek, B. &amp; Hrstka, R. (2011) Anterior gradient 2: a novel player in tumor cell biology. <i>Cancer Lett.<\/i>, 304, 1-7."},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chevet, E., Fessart, D., Delom, F., Mulot, A., Vojtesek, B., Hrstka, R., Murray, E., Gray, T. &amp; Hupp, T. (2013) Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. <i>Oncogene<\/i>, 32, 2499-2509.","DOI":"10.1038\/onc.2012.346"},{"key":"6","unstructured":"de Groen, P.C., Gores, G.J., LaRusso, N.F., Gunderson, L.L. &amp; Nagorney, D.M. (1999) Biliary tract cancers. <i>N. Engl. J. Med.<\/i>, 341, 1368-1378."},{"key":"7","unstructured":"Fritzsche, F.R., Dahl, E., Dankof, A., Burkhardt, M., Pahl, S., Petersen, I., Dietel, M. &amp; Kristiansen, G. (2007) Expression of AGR2 in non small cell lung cancer. <i>Histol. Histopathol.<\/i>, 22, 703-708."},{"key":"8","unstructured":"Ho, M.E., Quek, S.I., True, L.D., Morrissey, C., Corey, E., Vessella, R.L., Dumpit, R., Nelson, P.S., Maresh, E.L., Mah, V., Alavi, M., Kim, S.R., Bagryanova, L., Horvath, S., Chia, D., et al. (2013) Prostate cancer cell phenotypes based on AGR2 and CD10 expression. <i>Mod. Pathol.<\/i>, 26, 849-859."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hrstka, R., Nenutil, R., Fourtouna, A., Maslon, M.M., Naughton, C., Langdon, S., Murray, E., Larionov, A., Petrakova, K., Muller, P., Dixon, M.J., Hupp, T.R. &amp; Vojtesek, B. (2010) The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers. <i>Oncogene<\/i>, 29, 4838-4847.","DOI":"10.1038\/onc.2010.228"},{"key":"10","unstructured":"Iacobuzio-Donahue, C.A., Maitra, A., Olsen, M., Lowe, A.W., van Heek, N.T., Rosty, C., Walter, K., Sato, N., Parker, A., Ashfaq, R., Jaffee, E., Ryu, B., Jones, J., Eshleman, J.R., Yeo, C.J., et al. (2003) Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. <i>Am. J. Pathol.<\/i>, 162, 1151-1162."},{"key":"11","doi-asserted-by":"crossref","unstructured":"Innes, H.E., Liu, D., Barraclough, R., Davies, M.P., O\u2019Neill, P.A., Platt-Higgins, A., de Silva Rudland, S., Sibson, D.R. &amp; Rudland, P.S. (2006) Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. <i>Br. J. Cancer<\/i>, 94, 1057-1065.","DOI":"10.1038\/sj.bjc.6603065"},{"key":"12","unstructured":"Kim, H.S., Kang, S.H., Park, C.H., Yang, W.I., Jeung, H.C., Chung, H.C., Roh, J.K., Ahn, J.B., Kim, N.K., Min, B.S. &amp; Rha, S.Y. (2011) Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. <i>Oncol. Rep.<\/i>, 25, 717-727."},{"key":"13","unstructured":"Komiya, T., Tanigawa, Y. &amp; Hirohashi, S. (1999) Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice. <i>Biochim. Biophys. Acta<\/i>, 1444, 434-438."},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., Dahl, E., Hinzmann, B., Specht, T., Pervan, J., Stephan, C., Loening, S., Dietel, M. &amp; Rosenthal, A. (2005) Expression profiling of microdissected matched prostate cancer samples reveals CD166\/MEMD and CD24 as new prognostic markers for patient survival. <i>J. Pathol.<\/i>, 205, 359-376.","DOI":"10.1002\/path.1676"},{"key":"15","unstructured":"Lepreux, S., Bioulac-Sage, P. &amp; Chevet, E. (2011) Differential expression of the anterior gradient protein-2 is a conserved feature during morphogenesis and carcinogenesis of the biliary tree. <i>Liver Int.<\/i>, 31, 322-328."},{"key":"16","doi-asserted-by":"crossref","unstructured":"Maresh, E.L., Mah, V., Alavi, M., Horvath, S., Bagryanova, L., Liebeskind, E.S., Knutzen, L.A., Zhou, Y., Chia, D., Liu, A.Y. &amp; Goodglick, L. (2010) Differential expression of anterior gradient gene AGR2 in prostate cancer. <i>BMC Cancer<\/i>, 10, 680.","DOI":"10.1186\/1471-2407-10-680"},{"key":"17","unstructured":"Park, K., Chung, Y.J., So, H., Kim, K., Park, J., Oh, M., Jo, M., Choi, K., Lee, E.J., Choi, Y.L., Song, S.Y., Bae, D.S., Kim, B.G. &amp; Lee, J.H. (2011) AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. <i>Exp. Mol. Med.<\/i>, 43, 91-100."},{"key":"18","doi-asserted-by":"crossref","unstructured":"Park, S.W., Zhen, G., Verhaeghe, C., Nakagami, Y., Nguyenvu, L.T., Barczak, A.J., Killeen, N. &amp; Erle, D.J. (2009) The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. <i>Proc. Natl. Acad. Sci. USA<\/i>, 106, 6950-6955.","DOI":"10.1073\/pnas.0808722106"},{"key":"19","unstructured":"Pohler, E., Craig, A.L., Cotton, J., Lawrie, L., Dillon, J.F., Ross, P., Kernohan, N. &amp; Hupp, T.R. (2004) The Barrett\u2019s antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. <i>Mol. Cell. Proteomics<\/i>, 3, 534-547."},{"key":"20","doi-asserted-by":"crossref","unstructured":"Ramachandran, V., Arumugam, T., Wang, H. &amp; Logsdon, C.D. (2008) Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. <i>Cancer Res.<\/i>, 68, 7811-7818.","DOI":"10.1158\/0008-5472.CAN-08-1320"},{"key":"21","unstructured":"Ramirez-Merino, N., Aix, S.P. &amp; Cortes-Funes, H. (2013) Chemotherapy for cholangiocarcinoma: an update. <i>World J. Gastrointest. Oncol.<\/i>, 5, 171-176."},{"key":"22","unstructured":"Riener, M.O., Pilarsky, C., Gerhardt, J., Gr\u00fctzmann, R., Fritzsche, F.R., Bahra, M., Weichert, W. &amp; Kristiansen, G. (2009) Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma. <i>Histol. Histopathol.<\/i>, 24, 1121-1128."},{"key":"23","unstructured":"Salmans, M.L., Zhao, F. &amp; Andersen, B. (2013) The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. <i>Breast Cancer Res.<\/i>, 15, 204."},{"key":"24","doi-asserted-by":"crossref","unstructured":"Sasaki, M., Ikeda, H. &amp; Nakanuma, Y. (2007) Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. <i>Prog. Histochem. Cytochem.<\/i>, 42, 61-110.","DOI":"10.1016\/j.proghi.2007.02.001"},{"key":"25","unstructured":"Sasaki, T., Isayama, H., Nakai, Y. &amp; Koike, K. (2013) Current status of chemotherapy for the treatment of advanced biliary tract cancer. <i>Korean J. Intern. Med.<\/i>, 28, 515-524."},{"key":"26","unstructured":"Thompson, D.A. &amp; Weigel, R.J. (1998) hAG-2, the human homologue of the Xenopus laevis cement gland gene XAG-2, is coexpressed with estrogen receptor in breast cancer cell lines. <i>Biochem. Biophys. Res. Commun.<\/i>, 251, 111-116."},{"key":"27","unstructured":"Valle, J., Wasan, H., Palmer, D.H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S.P., Roughton, M. &amp; Bridgewater, J. (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. <i>N. Engl. J. Med.<\/i>, 362, 1273-1281."},{"key":"28","unstructured":"Zhang, Y., Forootan, S.S., Liu, D., Barraclough, R., Foster, C.S., Rudland, P.S. &amp; Ke, Y. (2007) Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. <i>Prostate Cancer Prostatic Dis.<\/i>, 10, 293-300."}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/234\/1\/234_83\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T20:02:47Z","timestamp":1619640167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/234\/1\/234_83\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.234.83","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}